ATE9059T1 - Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension. - Google Patents

Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.

Info

Publication number
ATE9059T1
ATE9059T1 AT80400129T AT80400129T ATE9059T1 AT E9059 T1 ATE9059 T1 AT E9059T1 AT 80400129 T AT80400129 T AT 80400129T AT 80400129 T AT80400129 T AT 80400129T AT E9059 T1 ATE9059 T1 AT E9059T1
Authority
AT
Austria
Prior art keywords
anhydrase inhibitors
intraocular hypertension
reduce intraocular
supplements containing
containing ophthalmic
Prior art date
Application number
AT80400129T
Other languages
English (en)
Inventor
Robert L. Smith
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE9059T1 publication Critical patent/ATE9059T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT80400129T 1980-01-28 1980-01-28 Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension. ATE9059T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP80400129A EP0033042B1 (de) 1980-01-28 1980-01-28 Ophthalmische kohlensaure Anhydrase-Inhibitoren enthaltende Einlagen zur Verringerung intraokularer Hypertension

Publications (1)

Publication Number Publication Date
ATE9059T1 true ATE9059T1 (de) 1984-09-15

Family

ID=8187357

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80400129T ATE9059T1 (de) 1980-01-28 1980-01-28 Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.

Country Status (3)

Country Link
EP (1) EP0033042B1 (de)
AT (1) ATE9059T1 (de)
DE (1) DE3068986D1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50901B1 (en) * 1980-03-04 1986-08-06 Merck & Co Inc Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
GB2155331B (en) * 1980-07-09 1988-09-01 Florida University Of Composition for reducing intraocular pressure
US4386098A (en) * 1981-11-03 1983-05-31 Merck & Co., Inc. 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
GB8623661D0 (en) * 1986-10-02 1986-11-05 Darougar S Ocular insert
US4824866A (en) * 1987-02-02 1989-04-25 Riker Laboratories, Inc. Anti-glaucoma use of trifluoromethanesulfonamide
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
IT1223150B (it) * 1987-11-18 1990-09-12 Ubaldo Conte Compressa per uso oftalmico e rilascio controllato della sostanza attiva
US5466233A (en) * 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
JP2002506461A (ja) * 1997-06-26 2002-02-26 メルク エンド カンパニー インコーポレーテッド 網膜及び視神経の健康の最適化方法
US6264971B1 (en) 1999-11-04 2001-07-24 Btg International Limited Ocular insert
ATE506929T1 (de) 2001-06-12 2011-05-15 Univ Johns Hopkins Med Reservoirvorrichtung für die intraokulare arzneimittelabgabe
EP1507513A1 (de) * 2002-05-24 2005-02-23 Dr. GERHARD MANN chem.-pharm. Fabrik GmbH Tropfbares ophthalmisches gelpräparat mit diclofenamid und timolol
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
PL2391419T3 (pl) 2009-01-29 2019-12-31 Forsight Vision4, Inc. Dostarczanie leku do tylnego odcinka
WO2011094170A1 (en) 2010-01-27 2011-08-04 Alcon Research, Ltd. Pulsatile peri-corneal drug delivery device
US10166142B2 (en) 2010-01-29 2019-01-01 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
PL2600812T3 (pl) 2010-08-05 2022-01-24 Forsight Vision4, Inc. Urządzenie do leczenia oczu
HRP20210587T1 (hr) 2010-08-05 2021-05-28 Forsight Vision4, Inc. Injekcijski aparat za dostavu lijeka
CN103153316B (zh) 2010-08-05 2015-08-19 弗赛特影像4股份有限公司 组合药物递送方法和设备
US20140031769A1 (en) 2010-11-19 2014-01-30 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
WO2013003620A2 (en) 2011-06-28 2013-01-03 Forsight Vision4, Inc. Diagnostic methods and apparatus
WO2013040247A2 (en) 2011-09-16 2013-03-21 Forsight Vision4, Inc. Fluid exchange apparatus and methods
CN103110575B (zh) * 2013-03-07 2014-11-05 宁夏康亚药业有限公司 一种美洛昔康滴眼液及其制备方法和应用
CA2905496A1 (en) 2013-03-14 2014-09-25 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
AU2014241163B2 (en) 2013-03-28 2018-09-27 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
AU2015301054B2 (en) 2014-08-08 2020-05-14 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
MX2018006234A (es) 2015-11-20 2018-08-14 Forsight Vision4 Inc Estructuras porosas para dispositivos de suministro de medicamentos de liberacion prolongada.
AU2018372806B2 (en) 2017-11-21 2024-05-30 Forsight Vision4, Inc. Fluid exchange apparatus for expandable port delivery system and methods of use
USD1033637S1 (en) 2022-01-24 2024-07-02 Forsight Vision4, Inc. Fluid exchange device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860371A (en) * 1958-07-03 1961-02-01 Pfizer & Co C Di-sulfonamides and compositions containing them
GB851287A (en) * 1958-07-10 1960-10-12 British Drug Houses Ltd 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent

Also Published As

Publication number Publication date
EP0033042A1 (de) 1981-08-05
DE3068986D1 (en) 1984-09-27
EP0033042B1 (de) 1984-08-22

Similar Documents

Publication Publication Date Title
ATE9059T1 (de) Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.
DE3167999D1 (en) Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
FI822414A0 (fi) Syror av n-substituerade 2-pyrrolidon-4-karboxylsyror som befuktningsmedel
HK28984A (en) Composition and method for combating virus infections
DE69326836D1 (de) Androgentherapie am auge beim sjögrensyndrom
ATE15596T1 (de) Pharmazeutische mittel.
IT8120609A0 (it) Configurazione d'elettrodo per migliorare la stabilita' dell'arco.
IT8024827A0 (it) Impiego dell'alfa-chetoglutarato di piridossina nella profilassi della iperlattacidemia.
ES8406461A1 (es) Procedimiento para la obtencion de benzofuranonas
ATE26273T1 (de) 3-indolcarboxamid-verbindungen.
NO178546C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive ACE-hemmere med nootrop virkning
DK43280A (da) Ophalmiske praeparater
EP0166183A3 (en) Use of hydroxyindole derivatives for lowering the blood pressure
ATE46332T1 (de) Spiro-imidazolidine als aldose-reduktaseinhibitoren.
MX166867B (es) Tampones absorbentes y metodo para prepararlos
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
ATE118007T1 (de) Penemderivate.
GB1530848A (en) 2-(phenylalkylhydrazono)-propionic acid derivatives
ATE11012T1 (de) Ophthalmische zusammensetzung, die 5-fluor-2methyl-1-(p-methylthio-benzyliden)-3-indenylessigs[ure oder deren salz enthaelt.
IT8024828A0 (it) Impiego dell'alfa-chetoglutarato di piridossina nella terapia della iperlattacidemia.
GB1511179A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee